See more : Gelteq Limited Ordinary Shares (GELS) Income Statement Analysis – Financial Results
Complete financial analysis of Da-Li Development Co.,Ltd. (6177.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Da-Li Development Co.,Ltd., a leading company in the Real Estate – Services industry within the Real Estate sector.
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) Income Statement Analysis – Financial Results
- Capella Minerals Limited (CMIL.V) Income Statement Analysis – Financial Results
- Glucose Health, Inc. (GLUC) Income Statement Analysis – Financial Results
- Stark Technology, Inc. (2480.TW) Income Statement Analysis – Financial Results
- Avecho Biotechnology Limited (AVEFF) Income Statement Analysis – Financial Results
Da-Li Development Co.,Ltd. (6177.TW)
About Da-Li Development Co.,Ltd.
Da-Li Development Co.,Ltd. operates as a full-service, multi-family, and diversified real estate investment and development company. Da-Li Development Co.,Ltd. was founded in 1977 and is headquartered in Taipei, Taiwan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.43B | 8.59B | 10.08B | 2.10B | 6.63B | 1.46B | 5.62B | 2.46B | 4.63B | 4.81B | 960.49M | 2.78B | 1.45B | 2.47B | 0.00 |
Cost of Revenue | 11.52B | 6.22B | 7.46B | 1.52B | 4.85B | 937.01M | 3.78B | 1.73B | 3.48B | 2.78B | 710.40M | 1.77B | 1.07B | 1.86B | 0.00 |
Gross Profit | 3.91B | 2.37B | 2.62B | 579.78M | 1.77B | 520.86M | 1.84B | 723.76M | 1.15B | 2.04B | 250.09M | 1.01B | 381.06M | 611.38M | 0.00 |
Gross Profit Ratio | 25.34% | 27.57% | 25.98% | 27.56% | 26.75% | 35.73% | 32.67% | 29.47% | 24.84% | 42.33% | 26.04% | 36.32% | 26.27% | 24.78% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 417.51M | 495.30M | 340.18M | 307.33M | 267.61M | 309.07M | 273.34M | 214.05M | 178.77M | 183.60M | 90.04M | 81.83M | 70.60M | 75.68M | 0.00 |
Selling & Marketing | 933.86M | 408.19M | 536.67M | 102.97M | 371.44M | 79.05M | 321.63M | 121.07M | 214.32M | 271.46M | 43.84M | 138.22M | 93.09M | 117.99M | 0.00 |
SG&A | 1.35B | 903.49M | 876.85M | 410.31M | 639.04M | 388.12M | 594.97M | 335.11M | 393.09M | 455.06M | 133.88M | 220.05M | 163.69M | 193.67M | 0.00 |
Other Expenses | 0.00 | 77.26M | 35.81M | 133.72M | 27.27M | 3.97M | 27.44M | 71.22M | 43.72M | 17.90M | 5.52M | 560.00K | 6.22M | 2.57M | 0.00 |
Operating Expenses | 1.35B | 903.49M | 876.85M | 410.31M | 639.04M | 388.12M | 594.97M | 335.11M | 393.09M | 455.06M | 133.88M | 220.05M | 163.69M | 193.67M | 0.00 |
Cost & Expenses | 12.87B | 7.12B | 8.34B | 1.93B | 5.49B | 1.33B | 4.38B | 2.07B | 3.88B | 3.23B | 844.28M | 1.99B | 1.23B | 2.05B | 0.00 |
Interest Income | 8.82M | 5.70M | 1.32M | 786.00K | 7.34M | 8.76M | 3.80M | 0.00 | 0.00 | 0.00 | 0.00 | 2.48M | 1.16M | 437.00K | 0.00 |
Interest Expense | 78.58M | 94.40M | 136.44M | 113.79M | 193.79M | 108.93M | 87.20M | 64.49M | 44.38M | 24.90M | 20.32M | 14.26M | 10.76M | 20.94M | 0.00 |
Depreciation & Amortization | 138.21M | 97.24M | 41.38M | 13.72M | 13.25M | 5.13M | 4.09M | 15.16M | 5.60M | 3.96M | 3.22M | 2.55M | 2.54M | 2.56M | 0.00 |
EBITDA | 2.87B | 1.69B | 1.81B | 330.77M | 1.21B | 165.71M | 1.27B | 475.03M | 807.26M | 1.60B | 124.95M | 245.63M | 275.98M | 378.66M | 0.00 |
EBITDA Ratio | 18.57% | 19.66% | 18.01% | 15.73% | 18.26% | 12.50% | 22.86% | 19.34% | 17.42% | 33.32% | 13.01% | 28.64% | 15.68% | 17.16% | 0.00% |
Operating Income | 2.56B | 1.59B | 1.77B | 291.01M | 1.17B | 132.74M | 1.24B | 388.65M | 757.95M | 1.58B | 116.21M | 790.53M | 217.37M | 417.71M | 0.00 |
Operating Income Ratio | 16.58% | 18.53% | 17.60% | 13.84% | 17.62% | 9.11% | 22.08% | 15.82% | 16.36% | 32.87% | 12.10% | 28.41% | 14.98% | 16.93% | 0.00% |
Total Other Income/Expenses | 89.77M | 32.56M | -92.38M | -1.39M | -167.57M | -81.07M | -59.75M | 6.72M | -659.00K | -7.00M | -14.80M | -22.44M | 45.31M | -62.55M | 0.00 |
Income Before Tax | 2.65B | 1.50B | 1.65B | 166.26M | 966.46M | 51.67M | 1.18B | 395.37M | 757.29M | 1.57B | 101.41M | 768.09M | 262.68M | 355.16M | 0.00 |
Income Before Tax Ratio | 17.17% | 17.41% | 16.32% | 7.90% | 14.58% | 3.54% | 21.01% | 16.10% | 16.35% | 32.72% | 10.56% | 27.60% | 18.11% | 14.40% | 0.00% |
Income Tax Expense | 572.20M | 296.53M | 85.43M | 16.76M | 57.73M | 6.18M | 44.40M | 26.85M | 42.15M | 51.30M | 63.08M | 6.45M | 3.59M | 5.65M | 0.00 |
Net Income | 2.07B | 1.20B | 1.56B | 158.08M | 922.05M | 47.31M | 1.14B | 368.52M | 715.14M | 1.52B | 38.34M | 761.64M | 259.09M | 349.51M | 0.00 |
Net Income Ratio | 13.41% | 13.96% | 15.52% | 7.52% | 13.91% | 3.25% | 20.22% | 15.00% | 15.44% | 31.66% | 3.99% | 27.37% | 17.86% | 14.17% | 0.00% |
EPS | 5.08 | 2.94 | 3.84 | 0.47 | 3.02 | 0.15 | 4.35 | 1.51 | 3.01 | 6.56 | 0.17 | 0.94 | 1.24 | 1.95 | 0.00 |
EPS Diluted | 4.82 | 2.94 | 3.84 | 0.41 | 2.75 | 0.15 | 3.70 | 1.16 | 2.25 | 5.93 | 0.17 | 0.87 | 1.16 | 1.58 | 0.00 |
Weighted Avg Shares Out | 407.45M | 407.31M | 407.31M | 335.92M | 304.95M | 319.55M | 260.79M | 244.21M | 238.24M | 232.28M | 229.49M | 216.94M | 208.65M | 179.50M | 228.47M |
Weighted Avg Shares Out (Dil) | 428.72M | 407.92M | 407.92M | 384.09M | 335.83M | 319.55M | 307.98M | 322.29M | 318.52M | 257.70M | 258.39M | 237.78M | 224.24M | 223.84M | 254.12M |
Source: https://incomestatements.info
Category: Stock Reports